CCA
TSVT

Column Capital Advisors’s 2seventy bio TSVT Stock Holding History

Column Capital Advisors’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$549 Hold
140
– – ﹤0.01% 747
2023
Q2 		$1.42K Hold
140
– – ﹤0.01% 730
2023
Q1 		$1.43K Hold
140
– – ﹤0.01% 741
2022
Q4 		$1.31K Hold
140
– – ﹤0.01% 738
2022
Q3 		$2K Hold
140
– – ﹤0.01% 649
2022
Q2 		$2K Hold
140
– – ﹤0.01% 652
2022
Q1 		$2K Hold
140
– – ﹤0.01% 665
2021
Q4 		$4K Buy
+140
New +$4.37K ﹤0.01% 610

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Column Capital Advisors's TSVT Position: Q3 2023 in Review

Column Capital Advisors held its 2seventy bio (TSVT) position steady in Q3 2023 at 140 shares worth $549. The position accounts for ﹤0.01% of the portfolio, ranked #747.

Column Capital Advisors first reported a position in TSVT in Q4 2021 and has held it in 8 quarters since. The position peaked at $4K in Q4 2021. 146 funds tracked by Wall St. Rank hold TSVT as of Q3 2023.

  • Column Capital Advisors held 140 shares of 2seventy bio worth $549 as of Q3 2023.
  • Column Capital Advisors left its 2seventy bio share count unchanged in Q3 2023.
  • 2seventy bio made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #747 holding.
  • Column Capital Advisors first reported a position in 2seventy bio in Q4 2021 and has held it in 8 quarters since.
  • Column Capital Advisors's 2seventy bio position peaked at $4K in Q4 2021.
  • 146 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.